Amy Schumer Discusses Mounjaro Use for Cushing Syndrome
The comedian shared how she lost 50 pounds while prioritizing her survival and health following a Cushing syndrome diagnosis.
Updated on Oct. 21, 2026 in Weight Loss

Live Poll
Do you trust celebrity public statements regarding their health and weight loss journeys?
Comedian Amy Schumer, 45, recently shared updates regarding her 50-pound weight loss and her health management following a diagnosis of Cushing syndrome. Schumer stated that her health journey, which included the use of Mounjaro, was driven by a need to focus on her well-being.
Why it matters
Cushing syndrome is a condition caused by an overproduction of cortisol, which can lead to significant health challenges and weight fluctuations. Understanding the difference between medically managed weight loss and cosmetic goals is a critical conversation for patients addressing chronic health issues with their doctors.
In a personal account of her health journey, the 45-year-old comedian reported a 50-pound weight loss associated with the use of Mounjaro. The clinical outcomes for patients using these medications specifically alongside a Cushing syndrome diagnosis remain a subject of ongoing observation.
The players
Amy Schumer
A 45-year-old comedian who has publicly shared her experience managing Cushing syndrome.
The details
Cushing syndrome occurs when the body is exposed to high levels of the hormone cortisol for a prolonged period, impacting metabolism and weight. Schumer noted that her use of Mounjaro, a medication that mimics hormones to regulate blood sugar and appetite, was part of a larger effort to manage her health rather than a focus on appearance. The comedian emphasized that her primary motivation for the transformation was personal survival.
Timeline
Several years earlier: Schumer previously tried Wegovy.
March 2025: Schumer discussed her medication use.
December 2025: Schumer clarified her weight loss amount.
October 2026: Schumer published vacation photos.
Health Landscape
The use of GLP-1 receptor agonists to address metabolic and hormonal dysregulation reflects a significant shift in managing conditions like Cushing syndrome. This approach represents an evolution in how clinicians treat complex weight and hormonal issues beyond traditional weight-loss interventions.
Patients dealing with weight management alongside hormonal conditions should discuss how specific medications interact with their unique health profiles during a consultation. It is essential to consult with an endocrinologist to determine if clinical weight-loss aids are appropriate for your specific health needs.
The takeaway
Weight management for those with diagnosed hormonal conditions like Cushing syndrome requires a clinical approach prioritized for survival and long-term health. Keep a detailed record of your symptoms and medication experiences to discuss with your primary care provider at your next checkup.
Further reading
Learn more about the current medical approaches to body composition and health in our Weight Loss section.
Live Poll
Do you trust celebrity public statements regarding their health and weight loss journeys?






